Discovery and engineering of the antibody response against a prominent skin commensal

Djenet Bousbaine,Katherine D. Bauman,Y. Erin Chen,Victor K. Yu,Pranav V. Lalgudi,Arash Naziripour,Alessandra Veinbachs,Jennie L. Phung,Tam T.D. Nguyen,Joyce M. Swenson,Yue E. Lee,Alex Dimas,Sunit Jain,Xiandong Meng,Thi Phuong Thao Pham,Aishan Zhao,Layla Barkal,Inta Gribonika,Koen K.A. Van Rompay,Yasmine Belkaid,Christopher O. Barnes,Michael A. Fischbach
DOI: https://doi.org/10.1101/2024.01.23.576900
2024-01-23
Abstract:The ubiquitous skin colonist elicits a CD8 T cell response pre-emptively, in the absence of an infection . However, the scope and purpose of this anti-commensal immune program are not well defined, limiting our ability to harness it therapeutically. Here, we show that this colonist also induces a potent, durable, and specific antibody response that is conserved in humans and non-human primates. A series of cell-wall mutants revealed that the cell surface protein Aap is a predominant target. By colonizing mice with a strain of in which the parallel β-helix domain of Aap is replaced by tetanus toxin fragment C, we elicit a potent neutralizing antibody response that protects mice against a lethal challenge. A similar strain of expressing an Aap-SpyCatcher chimera can be conjugated with recombinant immunogens; the resulting labeled commensal elicits high titers of antibody under conditions of physiologic colonization, including a robust IgA response in the nasal mucosa. Thus, immunity to a common skin colonist involves a coordinated T and B cell response, the latter of which can be redirected against pathogens as a novel form of topical vaccination.
Microbiology
What problem does this paper attempt to address?